ERWINAZE
Live / Registered — Registered (as of 03 Dec 2024)
What this means for you
Registered since 03 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90081574
- Registration number
- 7583279
- Mark type
- Design + words
- Filed
- 29 Jul 2020
- Published for opposition
- 01 Oct 2024
- Registered
- 03 Dec 2024
- Attorney of record
- Rebecca Liebowitz
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for treatment of blood cancer; pharmaceutical preparations and substances for the treatment of leukaemia; pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical compositions and preparations for treatment of leukaemia and cancer, namely, injectable pharmaceutical compositions comprising compounds having asparaginase activity
Owner
- Porton Biopharma Limited, Wiltshire, GB
- Porton Biopharma Limited, Wiltshire, GB
- Porton Biopharma Limited, Wiltshire, GB
Prior registrations
Prosecution history
- 03 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 01 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Oct 2024 — PUBLISHED FOR OPPOSITION
- 11 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Aug 2024 — CASE RETURNED TO EXAMINATION
- 28 Aug 2024 — NOTICE OF ALLOWANCE CANCELLED
- 27 Aug 2024 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 10 Jul 2024 — PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
- 08 Jul 2024 — ASSIGNED TO PETITION STAFF
- 30 May 2024 — TEAS PETITION TO AMEND BASIS RECEIVED
- 01 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Feb 2024 — SOU EXTENSION 5 GRANTED
- 29 Feb 2024 — SOU EXTENSION 5 FILED
- 29 Feb 2024 — SOU TEAS EXTENSION RECEIVED